Skip to main content
Log in

Cancer versus heart failure patient self-declared potential interest in clinical trials

  • Editor’s Commentary
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mills EJ, Seely D, Rahlis B, et al.:Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.Lancet Oncol 2006,7:141–148.

    Article  PubMed  Google Scholar 

  2. Markman M, Petersen J, Montgomery R:Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.Cancer 2006,107:849–853.

    Article  PubMed  Google Scholar 

  3. The American Heart Association. Classification of Functional Capacity and Objective Assessment. http://www.americanheart.org/presenter.jhtml?identifier=4569 (Accessed 8/23/06).

  4. O’Connell JB, Bristow MR:Economic impact of heart failure in the United States: Time for a different approach.J Heart Lung Transplant 1994,13(Suppl):S107-S112.

    PubMed  Google Scholar 

  5. Sontag S:Illness as Metaphor. New York: Vintage Books; 1977.

    Google Scholar 

  6. Donovan RJ, Carter OBJ, Byrne MJ:People’s perceptions of cancer survivability: implications for oncologists.Lancet Oncol 2006,7:668–675.

    Article  PubMed  Google Scholar 

  7. Stull DE, Starling R, Haas G, Young JB:Becoming a patient with heart failure.Heart Lung 1999,28:284–292.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurie Markman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M., Smoyer, L., Marron, J.T. et al. Cancer versus heart failure patient self-declared potential interest in clinical trials. Curr Oncol Rep 9, 1–5 (2007). https://doi.org/10.1007/BF02951419

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02951419

Keywords

Navigation